Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

被引：0
|
作者：
Kamal Chamoun
Hagop Kantarjian
Rami Atallah
Graciela Nogueras Gonzalez
Ghayas C. Issa
Mary Beth Rios
Guillermo Garcia-Manero
Gautam Borthakur
Farhad Ravandi
Nitin Jain
Naval Daver
Marina Konopleva
Courtney D. DiNardo
Tapan Kadia
Naveen Pemmaraju
Elias Jabbour
Jorge Cortes
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Leukemia
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
CML; TKI discontinuation; MR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
    Chamoun, Kamal
    Kantarjian, Hagop
    Atallah, Rami
    Gonzalez, Graciela Nogueras
    Issa, Ghayas C.
    Rios, Mary Beth
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Ravandi, Farhad
    Jain, Nitin
    Daver, Naval
    Konopleva, Marina
    DiNardo, Courtney D.
    Kadia, Tapan
    Pemmaraju, Naveen
    Jabbour, Elias
    Cortes, Jorge
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [2] Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Single US Center Experience
    Khoury, H. Jean
    Heffner, Leonard T., Jr.
    Arellano, Martha
    Jillella, Anand P.
    Kota, Vamsi K.
    Winton, Elliott F.
    BLOOD, 2015, 126 (23)
  • [3] Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Nishioka, Atsujiro
    Okamoto, Sho
    Katsuya, Hiroo
    Yoshimura, Mariko
    Kubota, Yasushi
    Ando, Toshihiko
    Kimura, Shinya
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (04) : 549 - 557
  • [4] Patient (Pt)-Driven Discontinuation of Tyrosine Kinase Inhibitor Theray in Chronic Phase Chronic Myeloid Leukemia (CML) - Single Institution Experience
    Benjamini, Ohad
    Kantarjian, Hagop M.
    Rios, Mary Beth
    Jabbour, Elias
    O'Brien, Susan
    Jain, Preetesh
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [5] Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution
    Iino, Masaki
    Yamamoto, Takeo
    Sakamoto, Yuma
    HEMATOLOGY, 2019, 24 (01) : 355 - 361
  • [6] Chronic Myeloid Leukemia—the Promise of Tyrosine Kinase Inhibitor Discontinuation
    Ravi Kishore Narra
    Kathryn E. Flynn
    Ehab Atallah
    Current Hematologic Malignancy Reports, 2017, 12 : 415 - 423
  • [7] Second Tyrosine Kinase Inhibitor Discontinuation Attempt in Patients With Chronic Myeloid Leukemia
    Legros, Laurence
    Nicolini, Franck E.
    Etienne, Gabriel
    Rousselot, Philippe
    Rea, Delphine
    Giraudier, Stephane
    Guerci-Bresler, Agnes
    Huguet, Francoise
    Gardembas, Martine
    Escoffre, Martine
    Ianotto, Jean-Christophe
    Noel, Marie-Pierre
    Varet, Bruno R.
    Pagliardini, Thomas
    Touitou, Irit
    Morisset, Stephane
    Mahon, Francois-Xavier
    CANCER, 2017, 123 (22) : 4403 - 4410
  • [8] The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients with Chronic Myeloid Leukemia, a Single Institution Experience
    Abu-Tineh, Mohammad
    Ali, Elrazi Awadelkarim A.
    Alshurafa, Awni
    Alhaj, Khalid
    Hailan, Yousef
    Kashgary, Waail Rozi
    Nashwan, Abdulqadir Jeprel
    Yassin, Mohamed A.
    BLOOD, 2021, 138
  • [9] Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: a single-center experience
    Frikha, R.
    Elloumi, M.
    Kamoun, H.
    LEUKEMIA RESEARCH, 2019, 85 : S66 - S66
  • [10] Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation
    Narra, Ravi Kishore
    Flynn, Kathryn E.
    Atallah, Ehab
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (05) : 415 - 423
12345